$BGXX
Bright Green Corp Stock $bgxx

$bgxx Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000149315223042095 Filed on November 20, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.320M	$1.651M	$5.637M
YoY Change	-9.07%	-70.72%	1184.81%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$160.9K	$160.9K	$140.3K
YoY Change	-9.58%	14.68%	-25.97%
% of Gross Profit
Operating Expenses	$1.481M	$1.812M	$5.777M
YoY Change	-9.13%	-68.64%	819.6%
Operating Profit		-$1.812M	-$5.777M
YoY Change		-68.64%	819.6%
Interest Expense	-$260.00	$0.00
YoY Change	-99.88%
% of Operating Profit
Other Income/Expense, Net	-$4.016M
YoY Change
Pretax Income	-$5.497M	-$1.812M	-$5.777M
YoY Change	198.35%	-68.64%	819.6%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$5.531M	-$1.991M	-$5.777M
YoY Change	179.68%	-65.53%	819.6%
Net Earnings / Revenue
Basic Earnings Per Share		-$0.01	-$0.04
Diluted Earnings Per Share	-$0.03	-$0.01	-$35.73K
COMMON SHARES
Basic Shares Outstanding	183.9M shares	179.6M shares	159.8M shares
Diluted Shares Outstanding		180.6M shares	161.7M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$10.06K	$121.7K	$4.062M
YoY Change	-97.57%	-97.0%	197.54%
Cash & Equivalents	$10.06K	$121.7K	$4.062M
Short-Term Investments
Other Short-Term Assets	$258.2K	$156.7K	$90.59K
YoY Change	231.7%	73.0%	9.11%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$268.3K	$278.4K	$4.153M
YoY Change	-45.52%	-93.3%	182.83%
LONG-TERM ASSETS
Property, Plant & Equipment	$16.41M	$19.14M	$12.42M
YoY Change	-4.31%	54.16%	72.09%
Goodwill
YoY Change
Intangibles	$1.000K	$1.000K	$1.000K
YoY Change	0.0%	0.0%
Long-Term Investments	$726.3K	$3.806M
YoY Change	437.41%
Other Assets	$0.00	$1.110M	$1.428M
YoY Change	-100.0%	-22.29%
Total Long-Term Assets	$17.13M	$24.06M	$13.85M
YoY Change	-23.15%	73.76%	91.87%
TOTAL ASSETS
Total Short-Term Assets	$268.3K	$278.4K	$4.153M
Total Long-Term Assets	$17.13M	$24.06M	$13.85M
Total Assets	$17.40M	$24.34M	$18.00M
YoY Change	-23.63%	35.21%	107.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.175M	$5.929M	$2.048M
YoY Change	-17.06%	189.5%	1026.08%
Accrued Expenses	$411.1K	$1.146M	$379.1K
YoY Change	-8.1%	202.35%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.236M	$8.725M	$2.819M
YoY Change	-17.11%	209.48%	1450.17%
LONG-TERM LIABILITIES
Long-Term Debt	$201.8K	$0.00	$0.00
YoY Change	-94.53%
Other Long-Term Liabilities			$2.035M
YoY Change			521.47%
Total Long-Term Liabilities	$201.8K		$2.034M
YoY Change	-94.53%		521.47%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.236M	$8.725M	$2.819M
Total Long-Term Liabilities	$201.8K		$2.034M
Total Liabilities	$6.438M	$8.725M	$4.854M
YoY Change	-42.57%	79.76%	853.14%
SHAREHOLDERS EQUITY
Retained Earnings	-$47.20M	-$41.67M	-$32.10M
YoY Change	38.52%	29.83%
Common Stock	$58.17M	$57.29M	$41.40M
YoY Change	27.41%	38.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$10.96M	$15.61M	$13.15M
YoY Change
Total Liabilities & Shareholders Equity	$17.40M	$24.34M	$18.00M
YoY Change	-23.63%	35.21%	107.25%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$5.531M	-$1.991M	-$5.777M
YoY Change	179.68%	-65.53%	819.6%
Depreciation, Depletion And Amortization	$160.9K	$160.9K	$140.3K
YoY Change	-9.58%	14.68%	-25.97%
Cash From Operating Activities	$17.83K	-$393.4K	-$804.2K
YoY Change	-99.14%	-51.08%	54.03%
INVESTING ACTIVITIES
Capital Expenditures	$329.5K	-$65.84K	-$3.001M
YoY Change	-93.29%	-97.81%
Acquisitions
YoY Change
Other Investing Activities		-$50.00K	-$1.428M
YoY Change		-96.5%
Cash From Investing Activities	-$329.5K	$15.84K	-$4.429M
YoY Change	-95.5%	-100.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	200.0K	-5.250K	9.117M
YoY Change	-87.5%	-100.06%	1732.62%
NET CHANGE
Cash From Operating Activities	17.83K	-393.4K	-804.2K
Cash From Investing Activities	-329.5K	15.84K	-4.429M
Cash From Financing Activities	200.0K	-5.250K	9.117M
Net Change In Cash	-111.7K	-382.8K	3.883M
YoY Change	-96.94%	-109.86%	-15854.44%
FREE CASH FLOW
Cash From Operating Activities	$17.83K	-$393.4K	-$804.2K
Capital Expenditures	$329.5K	-$65.84K	-$3.001M
Free Cash Flow	-$311.7K	-$327.6K	$2.197M
YoY Change	-88.98%	-114.91%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001886799
CY2023Q3	us-gaap	Long Term Line Of Credit LongTermLineOfCredit		usd
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent		usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2023Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax		usd
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax		usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax		usd
CY2023Q3	us-gaap	Other Expenses OtherExpenses		usd
CY2022Q3	us-gaap	Other Expenses OtherExpenses		usd
	us-gaap	Other Expenses OtherExpenses		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q3	BGXX	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest Equity In Net Losses Of Affiliate IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterestEquityInNetLossesOfAffiliate		usd
	BGXX	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest Equity In Net Losses Of Affiliate IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterestEquityInNetLossesOfAffiliate		usd
	BGXX	Equity In Net Losses Of Affiliate EquityInNetLossesOfAffiliate		usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet		usd
	BGXX	Payments For Acquire Property Deposits PaymentsForAcquirePropertyDeposits		usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	BGXX	Related Party Loc In Exchange For Common Stock And Warrants RelatedPartyLocInExchangeForCommonStockAndWarrants		usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41395
	dei	Entity Registrant Name EntityRegistrantName	BRIGHT GREEN CORPORATION
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-4600841
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1033 George Hanosh Boulevard
	dei	Entity Address City Or Town EntityAddressCityOrTown	Grants
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NM
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	87020
	dei	City Area Code CityAreaCode	(833)
	dei	Local Phone Number LocalPhoneNumber	658-1799
	dei	Entity Information Former Legal Or Registered Name EntityInformationFormerLegalOrRegisteredName	Not Applicable
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
	dei	Trading Symbol TradingSymbol	BGXX
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	183883818	shares
CY2023Q3	us-gaap	Cash Cash	121724	usd
CY2022Q4	us-gaap	Cash Cash	414574	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	156721	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	77847	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	278445	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	492421	usd
CY2023Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	1109643	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	1157587	usd
CY2023Q3	us-gaap	Equity Method Investments EquityMethodInvestments	3806310	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	3990960	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	19142289	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17146325	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1000	usd
CY2023Q3	us-gaap	Assets Assets	24337687	usd
CY2022Q4	us-gaap	Assets Assets	22788293	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	5928896	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5033831	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1146191	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	447325	usd
CY2023Q3	BGXX	Due To Others Current DueToOthersCurrent	1650000	usd
CY2022Q4	BGXX	Due To Others Current DueToOthersCurrent	1650000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	8725087	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7523350	usd
CY2022Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	3686107	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3686107	usd
CY2023Q3	us-gaap	Liabilities Liabilities	8725087	usd
CY2022Q4	us-gaap	Liabilities Liabilities	11209457	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	183883818	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	183883818	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	173304800	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	173304800	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	18388	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	17329	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	18388	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	17329	usd
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	57266711	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	45637328	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-41672499	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34075821	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	15612600	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11578836	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24337687	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22788293	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1650655	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5636736	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6933033	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	25157707	usd
CY2023Q3	us-gaap	Depreciation Depreciation	160878	usd
CY2022Q3	us-gaap	Depreciation Depreciation	140281	usd
	us-gaap	Depreciation Depreciation	477629	usd
	us-gaap	Depreciation Depreciation	526749	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	1811533	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	5777017	usd
	us-gaap	Operating Expenses OperatingExpenses	7410662	usd
	us-gaap	Operating Expenses OperatingExpenses	25684456	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1811533	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5777017	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7410662	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-25684456	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1366	usd
	us-gaap	Other Expenses OtherExpenses	1366	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1811533	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5777017	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7412028	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-25684456	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1811533	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-5777017	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-7412028	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-25684456	usd
CY2023Q3	BGXX	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest Equity In Net Losses Of Affiliate IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterestEquityInNetLossesOfAffiliate	-179709	usd
	BGXX	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest Equity In Net Losses Of Affiliate IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterestEquityInNetLossesOfAffiliate	-184650	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1991242	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-5777017	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7596678	usd
	us-gaap	Net Income Loss NetIncomeLoss	-25684456	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	180587574	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	180587574	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	161681844	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	161681844	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	176784628	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	176784628	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	159394535	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	159394535	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	13320800	usd
CY2023Q3	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	10000	usd
CY2023Q3	BGXX	Common Stock And Warrants Issued For Cashless Conversion Of Related Party Line Of Credit CommonStockAndWarrantsIssuedForCashlessConversionOfRelatedPartyLineOfCredit	3609789	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	673253	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1991242	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	15612600	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11578836	usd
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	395250	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	3104750	usd
	BGXX	Stock Issued During Period Value Warrants Exercised For Cash StockIssuedDuringPeriodValueWarrantsExercisedForCash	210000	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	880000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	10000	usd
	BGXX	Common Stock And Warrants Issued For Cashless Conversion Of Related Party Line Of Credit CommonStockAndWarrantsIssuedForCashlessConversionOfRelatedPartyLineOfCredit	3609789	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	880000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	2945903	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7596678	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	15612600	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	5941428	usd
CY2022Q3	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	863267	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	9136733	usd
CY2022Q3	BGXX	Stock Issued During Period Value Stock To Be Issued For Services StockIssuedDuringPeriodValueStockToBeIssuedForServices	3844500	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-5777017	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	13145644	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	8220399	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3050000	usd
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	863267	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	9136733	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	14595920	usd
	BGXX	Stock Issued During Period Value Stock To Be Issued For Services StockIssuedDuringPeriodValueStockToBeIssuedForServices	3844500	usd
	BGXX	Stock Cancelled During Period Value Issued For Services StockCancelledDuringPeriodValueIssuedForServices	-17452	usd
	us-gaap	Net Income Loss NetIncomeLoss	-25684456	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	13145644	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7596678	usd
	us-gaap	Net Income Loss NetIncomeLoss	-25684456	usd
	BGXX	Equity In Net Losses Of Affiliate EquityInNetLossesOfAffiliate	184650	usd
	us-gaap	Depreciation Depreciation	477629	usd
	us-gaap	Depreciation Depreciation	526749	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2945903	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	18422968	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	78874	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-77632	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	895065	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1898070	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	698866	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	361065	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	54507	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2473439	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4343465	usd
	BGXX	Payments For Acquire Property Deposits PaymentsForAcquirePropertyDeposits	1427973	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2204161	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5615393	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2204161	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7043366	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	200000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	3491057	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	1511067	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	880000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3050000	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	3104750	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	9136733	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	3104750	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	9136733	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	10000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	210000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4384750	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14166723	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-292850	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2779892	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	414574	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1282565	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	121724	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4062457	usd
	BGXX	Transfer From Due To Related Party To Related Party Loc TransferFromDueToRelatedPartyToRelatedPartyLOC	392194	usd
	us-gaap	Stock Issued1 StockIssued1	880000	usd
	BGXX	Related Party Loc In Exchange For Common Stock And Warrants RelatedPartyLocInExchangeForCommonStockAndWarrants	3619789	usd
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2019-04-16
	us-gaap	Revenues Revenues	0	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7596678	usd
	us-gaap	Net Income Loss NetIncomeLoss	-25684456	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2473439	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4343465	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-41672499	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34075821	usd
CY2023Q3	BGXX	Working Capital Deficit WorkingCapitalDeficit	8446642	usd
CY2022Q4	BGXX	Working Capital Deficit WorkingCapitalDeficit	7030929	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	3104750	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	880000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	210000	usd
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	200000	usd
CY2023Q3	us-gaap	Line Of Credit LineOfCredit	15000000	usd
	us-gaap	Proceeds From Payments For Long Term Loans For Related Parties ProceedsFromPaymentsForLongTermLoansForRelatedParties	392194	usd
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	880000	usd
	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	22005	shares
CY2023Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	39.99
CY2023Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2827960	shares
CY2023Q3	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	15000000	usd
	us-gaap	Advertising Expense AdvertisingExpense	33596	usd
	us-gaap	Advertising Expense AdvertisingExpense	67405	usd
	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination.
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_849_eus-gaap--UseOfEstimates_zVvTnNzGc515" style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">L. <span id="xdx_868_zBUtMTfSmkba"><span style="text-decoration: underline">Use of Estimates</span></span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. This applies in particular to valuation allowance for deferred tax assets, valuation of warrants and stock-based compensation, going concern assessment, and assignment of the useful lives of property, plant, and equipment. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q4	us-gaap	Time Deposit Liability Above Us Insurance Limit TimeDepositLiabilityAboveUsInsuranceLimit	187821	usd
CY2023Q2	BGXX	Equity In Net Losses Of Affiliate EquityInNetLossesOfAffiliate	179709	usd
CY2023Q3	BGXX	Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stocks Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStocksMaximum	0.75	pure
CY2023Q3	BGXX	Settlement Of Liability Outstanding SettlementOfLiabilityOutstanding	1650000	usd
CY2023Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	88690	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	88690	usd
CY2023Q3	us-gaap	Land Land	260000	usd
CY2022Q4	us-gaap	Land Land	260000	usd
CY2023Q3	us-gaap	Construction In Progress Gross ConstructionInProgressGross	13209862	usd
CY2022Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	10736269	usd
CY2023Q3	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	8883851	usd
CY2022Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	8883851	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	22442403	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	19968810	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3300114	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2822485	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	19142289	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17146325	usd
CY2023Q3	us-gaap	Finite Lived License Agreements Gross FiniteLivedLicenseAgreementsGross	1000	usd
CY2022Q4	us-gaap	Finite Lived License Agreements Gross FiniteLivedLicenseAgreementsGross	1000	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1000	usd
CY2022Q4	us-gaap	Construction Contract Cost Progress Payment Offset ConstructionContractCostProgressPaymentOffset	47944	usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	392194	usd
CY2023Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	880000	usd
CY2023Q1	us-gaap	Transfer To Investments TransferToInvestments	880000	usd
CY2023Q1	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	22005	shares
CY2023Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	39.99
CY2023Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	200000	usd
CY2023Q3	us-gaap	Line Of Credit LineOfCredit	3619789	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2827960	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	1.15
CY2023Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.13
CY2023Q3	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	2827960	shares
CY2023Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	3.00
CY2023Q3	BGXX	Capital Transaction Due To Related Party CapitalTransactionDueToRelatedParty	2090564	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	183883818	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	183883818	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	173304800	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	173304800	shares
CY2023Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	880000	usd
CY2023Q1	us-gaap	Transfer To Investments TransferToInvestments	880000	usd
CY2023Q3	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	2827960	shares
CY2023Q3	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	3619789	usd
CY2023Q3	us-gaap	Transfer To Investments TransferToInvestments	3619789	usd
	BGXX	Warrant Redeemed Or Called During Period Shares WarrantRedeemedOrCalledDuringPeriodShares	200000	shares
	BGXX	Warrant Redeemed Or Called During Period Value WarrantRedeemedOrCalledDuringPeriodValue	210000	usd
CY2022Q3	us-gaap	Professional Fees ProfessionalFees	800000	usd
CY2022Q3	us-gaap	Legal Fees LegalFees	55617	usd
CY2022Q3	us-gaap	Escrow Deposit EscrowDeposit	7650	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	316850	usd
CY2023Q2	us-gaap	Legal Fees LegalFees	78400	usd
CY2022Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	7399000	usd
CY2022Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	6901000	usd
CY2022Q3	BGXX	Decrease In Fair Value Of Warrants DecreaseInFairValueOfWarrants	498000	usd
	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<p id="xdx_804_eus-gaap--LossContingencyDisclosures_z9ExAkb2Cdl2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13. <span id="xdx_822_zsWV4xA4RuQ8"><span style="text-decoration: underline">Contingencies</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the ordinary course of business, the Company is routinely a defendant in, or party to a number of pending and threatened legal actions including actions brought on behalf of various classes of claimants. In view of the inherent difficulty of predicting the outcome of such matters, the Company cannot state what the eventual outcome of such matters will be. Legal provisions are established when it becomes probable that the Company will incur an expense related to a legal action and the amount can be reliably estimated. Such provisions are recorded at the best estimate of the amount required to settle any obligation related to these legal actions as at the balance sheet date, taking into account the risks and uncertainties surrounding the obligation. Management and internal and external experts are involved in estimating any amounts that may be required. The actual costs of resolving these claims may vary significantly from the amount of the legal provisions. The Company’s estimate involves significant judgement, given the varying stages of the proceedings, the fact that the Company’s liability, if any, has yet to be determined and the fact that the underlying matters will change from time to time. Other than as set forth below, the Company is not presently a party to any litigation. The Company is not able to make a reliable assessment of the potential losses as these matters are at an early stage, accordingly, no amounts have been accrued in the condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Bright Green Corporation v. John Fikany, State of New Mexico, County of Cibola, Thirteenth Judicial District</i>. In this matter, the Company filed a complaint for declaratory judgment against a consultant of the Bright Green Group of Companies, an entity unrelated to the Company, to determine if defendant is entitled to 5,000,000 shares of the Company’s common stock, based on a failure to fulfill agreed upon conditions precedent to earning such shares from the Company. Defendant counterclaimed and filed a third-party claim against a director of the Company, and her spouse, for claims including wrongful termination and breach of contract. The Company denies defendants allegations and have set forth arguments refuting defendant’s counterclaims and third-party claims. The case is in the discovery phase. The Company is exploring potential dispositive motions against the counter and third-party claims.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BRIGHT GREEN CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes to the Condensed Consolidated Financial Statements (Unaudited)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Three and Nine Months Ended September 30, 2023 and 2022</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Expressed in United States Dollars)</span></p> <div style="margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt"><span style="font-family: Times New Roman, Times, Serif"> </span></div></div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13. <span style="text-decoration: underline">Contingencies (continued)</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Bright Green Corporation v. Jerry Capussi, State of New Mexico, County of Cibola, Thirteenth Judicial District</i>. In this matter, the Company and defendant, a former consultant of Sunnyland Farms Inc., an entity unrelated to the Company, have each filed claims for declaratory judgment seeking to determine by court order whether defendant is entitled to <span id="xdx_909_eus-gaap--LossContingencyActionsTakenByDefendant_c20230101__20230930_zsL6cMvYb4Ee" title="Contingency, taken by defendant description">(i) shares of common stock in the Company (amounting to no more than 108,000 shares) or (ii) fair market value of defendant’s equity ownership of Bright Green Grown Innovation LLC. The lawsuit is in early discovery stages, and the Company is preparing arguments for a summary judgment motion. There are no claims for specific monetary liability against either party.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Loss Contingency Actions Taken By Defendant LossContingencyActionsTakenByDefendant	(i) shares of common stock in the Company (amounting to no more than 108,000 shares) or (ii) fair market value of defendant’s equity ownership of Bright Green Grown Innovation LLC. The lawsuit is in early discovery stages, and the Company is preparing arguments for a summary judgment motion. There are no claims for specific monetary liability against either party.

Files In Submission

Name	View Source	Status
0001493152-23-042095-index-headers.html	Edgar Link	pending
0001493152-23-042095-index.html	Edgar Link	pending
0001493152-23-042095.txt	Edgar Link	pending
0001493152-23-042095-xbrl.zip	Edgar Link	pending
bgxx-20230930.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
form10-q_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
bgxx-20230930_cal.xml	Edgar Link	unprocessable
bgxx-20230930_pre.xml	Edgar Link	unprocessable
bgxx-20230930_def.xml	Edgar Link	unprocessable
bgxx-20230930_lab.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BGXX
Bright Green Corp Stock $bgxx

2023 Q4 Form 10-Q Financial Statement

#000149315223042095 Filed on November 20, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BGXX Bright Green Corp Stock $bgxx

2023 Q4 Form 10-Q Financial Statement

#000149315223042095 Filed on November 20, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BGXX
Bright Green Corp Stock $bgxx